Patients who are unresponsive to 4–8 weeks' treatment with PPIs twice daily might have so-called refractory GERD. The first investigation these patients should undergo is upper endoscopy to ...

off-label treatments, such as stomach acid reducers (proton pump inhibitors) or asthma steroid medications (which are swallowed to coat the esophagus rather than inhaled) and stretching the ...

In such patients, treatment with proton pump inhibitors (PPIs) is more effective for healing esophagitis and improving ... the efficacy of acid-reducing drug treatment in achieving complete ...

The only treatment options for the condition ... ESO-101 gained Orphan Drug Designation for eosinophilic esophagitis in the USA in 2019, and an application has been submitted in Europe.

Pill esophagitis is most likely to occur when ... size-fits-all approach to treating esophagitis and reducing symptoms.

Vomiting so frequent and forceful that it can perforate the esophagus. Blood pressure and heart ... One is the lack of Food ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...

With a diverse drug portfolio and a robust pipeline of future drugs to market, this big pharma brand will play a major role ...

It’s an immunotherapy drug. Chemotherapy is a type of cancer treatment that kills cancer ... junction (where your stomach and esophagus connect). Keytruda is used when the cancer is advanced ...

Your esophagus carries ... receptor (EGFR). A drug called cetuximab works by targeting EGFR. Targeted drugs may be used together with radiation, chemotherapy, or other treatments.

Allergic reactions come in all varieties. One can even trigger a digestive disease called Eosinophilic Esophagitis, which ...

as a treatment of the chronic disease eosinophilic esophagitis. Data describing the pharmacokinetic profile, safety and tolerability of the drug candidate was evaluated between every dose escalation.